Cargando…
Innovative trial approaches in immune-mediated inflammatory diseases: current use and future potential
BACKGROUND: Despite progress that has been made in the treatment of many immune-mediated inflammatory diseases (IMIDs), there remains a need for improved treatments. Randomised controlled trials (RCTs) provide the highest form of evidence on the effectiveness of a potential new treatment regimen, bu...
Autores principales: | Grayling, Michael J., Bigirumurame, Theophile, Cherlin, Svetlana, Ouma, Luke, Zheng, Haiyan, Wason, James M. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252241/ https://www.ncbi.nlm.nih.gov/pubmed/34210348 http://dx.doi.org/10.1186/s41927-021-00192-5 |
Ejemplares similares
-
Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods
por: Ouma, Luke Ondijo, et al.
Publicado: (2021) -
Bayesian modelling strategies for borrowing of information in randomised basket trials
por: Ouma, Luke O., et al.
Publicado: (2022) -
Design and analysis of umbrella trials: Where do we stand?
por: Ouma, Luke O., et al.
Publicado: (2022) -
Current practices in studies applying the target trial emulation framework: a protocol for a systematic review
por: Bigirumurame, Theophile, et al.
Publicado: (2023) -
Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores
por: Cherlin, Svetlana, et al.
Publicado: (2020)